glp-1 hurst tx Shots GLP-1 and Health: Beyond Weight
Description
doi: 10.1016/j.peptides.2005.02.016
Conversely, GE is accelerated and GLP-1 release decreases significantly, following effective therapy (164)
Food and Drug Administration Adverse Events Database, where the spontaneous reporting rates of pancreatic and thyroid cancers were 2.9 and 4.7 times higher, respectively, with exenatide compared with other oral antidiabetic drugs [10]
Analysts predict this figure could quadruple over the next decade, reaching or even exceeding $150 billion by the early 2030s, particularly as the drugs' therapeutic applications expand
